Doctorglasses Chain Co (300622) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 5.0B CNY
Fair value as of: Jul 9, 2026
From 24 valuation models · updated 32 days ago
Share price +12.1% over the past month.
A solid business, but screening 44% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥10.89). The favourable scenario is already priced in.
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.
How to read this chart
60‑month range ¥6.12 – ¥31.82 · fair‑value band ¥6.54 – ¥10.89 · the ¥15.68 price screens above the ¥8.71 fair value. Dashed = 300-day average. As of Jul 9, 2026.
Analysis
Doctorglasses Chain Co (300622) currently trades at ¥15.68, while our model-based Fair Value estimate is ¥8.71, implying the stock looks roughly 44.4% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Doctorglasses Chain Co generated revenue of 1.4B CNY at a net margin of 11.4%. Revenue grew 8.3% year over year. It earns a return on equity of 18.6%. The balance sheet holds a net cash position of 28.9M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥6.54 (bear case) to ¥10.89 (bull case); at ¥15.68, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -24% fair-value upside, at -44%, 300622 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (¥15.59) versus Asset-Based (¥1.91). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Doctorglasses Chain Co.,Ltd. engages in the retail of eyewear in China. It offers optical glasses; smart glasses; ready-to-wear glasses series, including sunglasses, reading glasses, etc.; contact lenses; soft/hard contact lenses; care solutions, and eye health peripheral products.
Full company description
Doctorglasses Chain Co.,Ltd. engages in the retail of eyewear in China. It offers optical glasses; smart glasses; ready-to-wear glasses series, including sunglasses, reading glasses, etc.; contact lenses; soft/hard contact lenses; care solutions, and eye health peripheral products. The company provides eye examinations and fitting, wearing, and debugging, to after-sales visit. It sells its products through its store brands comprising doctor glasses, President Optical, Boojing, zèle, Concrete, and ZORRO, as well as through e-commerce and franchise channels. Doctorglasses Chain Co.,Ltd. was founded in 1993 and is headquartered in Shenzhen, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Doctorglasses Chain Co reported revenue of ¥1.4B in FY2025 versus ¥887M in FY2021, a compound +11.3%/yr. Reported net income was ¥149M in FY2025, compounding +11.9%/yr from FY2021.
300622 screens 44% overvalued. Compare with Casey's General Stores, Inc →
Peer Group
Specialty Retail · 221 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Retail stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Casey's General Stores, Inc CASY | $827.04 | $405.44 | -51% |
| Williams-Sonoma, Inc WSM | $222.84 | $164.16 | -26% |
| Ulta Beauty, Inc ULTA | $479.57 | $488.39 | +2% |
| DICK'S Sporting Goods, Inc DKS | $208.89 | $181.10 | -13% |
| Best Buy Co BBY | $83.98 | $109.12 | +30% |
| China Tourism Group 601888 | ¥52.90 | ¥40.40 | -24% |
| Tractor Supply Company TSCO | $31.01 | $35.52 | +15% |
| Murphy USA Inc MUSA | $618.57 | $423.35 | -32% |
| Five Below, Inc FIVE | $197.71 | $117.29 | -41% |
| Taiwan Mobile Co 3045 | 110.50 TWD | 80.98 TWD | -27% |
Compare Doctorglasses Chain Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Doctorglasses Chain Co (300622) overvalued or undervalued?
What is the fair value of 300622?
What is the quality score of 300622?
What is the revenue of Doctorglasses Chain Co (300622)?
What is the net profit margin of 300622?
Does Doctorglasses Chain Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Doctorglasses Chain Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.